Global Perspectives on Biomarker-Driven Therapeutic Strategies in Pancreatic Cancer

Download this slideset to review the latest global perspectives on biomarker-driven therapeutic strategies for patients with pancreatic cancer.
Philip Agop Philip, MD, PhD, FRCP
Format: Microsoft PowerPoint (.ppt)
File Size: 807 KB
Released: January 20, 2021

Acknowledgements

Supported by an educational grant from
AstraZeneca

Related Content

In this short slideset from Clinical Care Options (CCO), experts review second-line treatment options for advanced pancreatic cancer

Andrew H. Ko, MD Released: February 19, 2021

Video of expert discussion of second-line therapy for metastatic pancreatic cancer from Clinical Care Options (CCO)

Andrew H. Ko, MD
Program Director
Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: February 19, 2021 Expired: February 18, 2022

In this short slideset from Clinical Care Options (CCO), experts review first-line treatment options for advanced pancreatic cancer

Andrew H. Ko, MD Released: February 17, 2021

Video of expert discussion of first-line therapy for metastatic pancreatic cancer from Clinical Care Options (CCO)

Andrew H. Ko, MD
Program Director
Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: February 17, 2021 Expired: February 16, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue